Exchange: NASDAQ·Updated 03:05 PM EDT
INCY logo

INCY Incyte Corp.

$127.87
$0.13
(0.10%)
Today
EarningsOct 27
Mkt Cap$25.95B
Vol301,547.00

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
50

Neutral Sentiment

How do you feel about INCY?

Advertisement|Remove ads.